0001209191-21-028377.txt : 20210426
0001209191-21-028377.hdr.sgml : 20210426
20210426181006
ACCESSION NUMBER: 0001209191-21-028377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210422
FILED AS OF DATE: 20210426
DATE AS OF CHANGE: 20210426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horn Patrick Taylor
CENTRAL INDEX KEY: 0001572002
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 21855312
MAIL ADDRESS:
STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC.
STREET 2: 480 ARSENAL STREET, SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-22
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001572002
Horn Patrick Taylor
C/O ALBIREO PHARMA, INC.
10 POST OFFICE SQUARE, SUITE 1000
BOSTON
MA
02109
0
1
0
0
Chief Medical Officer
Common Stock
2021-04-22
4
S
0
90
31.75
D
11893
D
Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Represents 4,205 shares of common stock and 7,688 restricted stock units. Includes 940 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2019, 13 shares of common stock acquired under the ESPP on November 30, 2019, and 1,205 shares of common stock acquired under the ESPP on May 31, 2020.
/s/ Jason Duncan, Attorney-in-fact
2021-04-26